{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T04:50:38Z","timestamp":1794977438760,"version":"4.9.1"},"reference-count":180,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["One Health Outlook"],"DOI":"10.1186\/s42522-025-00144-w","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T18:03:36Z","timestamp":1744221816000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Advancement in diagnostic approaches for latent tuberculosis: distinguishing recent from remote infections"],"prefix":"10.1186","volume":"7","author":[{"given":"Yi En","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew Tze Jian","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohd Nor","family":"Norazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venugopal","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6707-9505","authenticated-orcid":false,"given":"Gee Jun","family":"Tye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,10]]},"reference":[{"key":"144_CR1","doi-asserted-by":"publisher","first-page":"5202","DOI":"10.3390\/ijms24065202","volume":"24","author":"SSR Alsayed","year":"2023","unstructured":"Alsayed SSR, Gunosewoyo H. Tuberculosis: pathogenesis, current treatment regimens and new drug targets. Int J Mol Sci. 2023;24:5202.","journal-title":"Int J Mol Sci"},{"key":"144_CR2","doi-asserted-by":"publisher","first-page":"220166","DOI":"10.1183\/20734735.0166-2022","volume":"19","author":"R Villar-Hern\u00e1ndez","year":"2023","unstructured":"Villar-Hern\u00e1ndez R, Ghodousi A, Konstantynovska O, Duarte R, Lange C, Raviglione M. Tuberculosis: current challenges and beyond. Breathe. 2023;19:220166.","journal-title":"Breathe"},{"key":"144_CR3","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1128\/iai.64.6.2062-2069.1996","volume":"64","author":"LG Wayne","year":"1996","unstructured":"Wayne LG, Hayes LG. An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence. Infect Immun. 1996;64:2062\u20139.","journal-title":"Infect Immun"},{"key":"144_CR4","unstructured":"World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva: World Health Organization; 2018. [cited 2024 Jul 17]. Available from: https:\/\/iris.who.int\/handle\/10665\/260233"},{"key":"144_CR5","doi-asserted-by":"publisher","first-page":"e1002152","DOI":"10.1371\/journal.pmed.1002152","volume":"13","author":"RMGJ Houben","year":"2016","unstructured":"Houben RMGJ, Dodd PJ. The global burden of latent tuberculosis infection: a re-estimation using mathematical modelling. PLOS Med. 2016;13:e1002152.","journal-title":"PLOS Med"},{"key":"144_CR6","doi-asserted-by":"publisher","first-page":"e1200","DOI":"10.1002\/iid3.1200","volume":"12","author":"AB Shrestha","year":"2024","unstructured":"Shrestha AB, Siam IS, Tasnim J, Dahal A, Roy P, Neupane S, et al. Prevalence of latent tuberculosis infection in Asian nations: a systematic review and meta-analysis. Immun Inflamm Dis. 2024;12:e1200.","journal-title":"Immun Inflamm Dis"},{"key":"144_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.14745\/ccdr.v43i34a01","volume":"43","author":"S Kiazyk","year":"2017","unstructured":"Kiazyk S, Ball T. Latent tuberculosis infection: an overview. Can Commun Dis Rep. 2017;43:62\u20136.","journal-title":"Can Commun Dis Rep"},{"key":"144_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1164\/ajrccm.153.1.8542139","volume":"153","author":"AL Kritski","year":"1996","unstructured":"Kritski AL, Marques MJ, Rabahi MF, Vieira MA, Werneck-Barroso E, Carvalho CE, et al. Transmission of tuberculosis to close contacts of patients with multidrug-resistant tuberculosis. Am J Respir Crit Care Med. 1996;153:331\u20135.","journal-title":"Am J Respir Crit Care Med"},{"key":"144_CR9","doi-asserted-by":"crossref","unstructured":"Sterling TR. Guidelines for the treatment of latent tuberculosis infection: recommendations from the National Tuberculosis Controllers Association and CDC, 2020. MMWR Recomm Rep. 2020;69. [cited 2024 Jul 17]. Available from: https:\/\/www.cdc.gov\/mmwr\/volumes\/69\/rr\/rr6901a1.htm","DOI":"10.15585\/mmwr.rr6901a1"},{"key":"144_CR10","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/S0041-3879(82)80013-5","volume":"63","author":"I Sutherland","year":"1982","unstructured":"Sutherland I, Svandov\u00e1 E, Radhakrishna S. The development of clinical tuberculosis following infection with tubercle bacilli. 1. A theoretical model for the development of clinical tuberculosis following infection, linking from data on the risk of tuberculous infection and the incidence of clinical tuberculosis in the Netherlands. Tubercle. 1982;63:255\u201368.","journal-title":"Tubercle."},{"key":"144_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/oxfordjournals.aje.a121593","volume":"99","author":"GW Comstock","year":"1974","unstructured":"Comstock GW, Livesay VT, Woolpert SF. The prognosis of a positive tuberculin reaction in childhood and adolescence. Am J Epidemiol. 1974;99:131\u20138.","journal-title":"Am J Epidemiol"},{"key":"144_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/EDE.0000000000001271","volume":"32","author":"NA Menzies","year":"2021","unstructured":"Menzies NA, Swartwood N, Testa C, Malyuta Y, Hill AN, Marks SM, et al. Time since infection and risks of future disease for individuals with mycobacterium tuberculosis infection in the United States. Epidemiol Camb Mass. 2021;32:70\u20138.","journal-title":"Epidemiol Camb Mass"},{"key":"144_CR13","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijid.2022.05.029","volume":"122","author":"C Ding","year":"2022","unstructured":"Ding C, Hu M, Guo W, Hu W, Li X, Wang S, et al. Prevalence trends of latent tuberculosis infection at the global, regional, and country levels from 1990\u20132019. Int J Infect Dis. 2022;122:46\u201362.","journal-title":"Int J Infect Dis"},{"key":"144_CR14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1164\/rccm.202011-4239PP","volume":"204","author":"MA Behr","year":"2021","unstructured":"Behr MA, Kaufmann E, Duffin J, Edelstein PH, Ramakrishnan L. Latent tuberculosis: two centuries of confusion. Am J Respir Crit Care Med. 2021;204:142\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"144_CR15","unstructured":"Gilani B, Sergent SR. Interferon test. StatPearls. Treasure Island: StatPearls Publishing; 2024. [cited 2024 Jul 18]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK560585\/"},{"key":"144_CR16","unstructured":"Pahal P, Pollard EJ, Sharma S. PPD Skin Test. StatPearls. Treasure Island: StatPearls Publishing; 2024. [cited 2024 Jul 18]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK556037\/"},{"key":"144_CR17","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.3390\/ijerph16162912","volume":"16","author":"S Adams","year":"2019","unstructured":"Adams S, Ehrlich R, Baatjies R, Dendukuri N, Wang Z, Dheda K. Evaluating latent tuberculosis infection test performance using latent class analysis in a TB and HIV endemic setting. Int J Environ Res Public Health. 2019;16:2912.","journal-title":"Int J Environ Res Public Health"},{"key":"144_CR18","doi-asserted-by":"crossref","unstructured":"Brett K, Severn M. Interferon gamma release assay for identifying latent tuberculosis infection in people with bacillus Calmette-Gu\u00e9rin vaccination. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2021. [cited 2024 Jul 18]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK583753\/","DOI":"10.51731\/cjht.2021.65"},{"key":"144_CR19","doi-asserted-by":"publisher","first-page":"e0169539","DOI":"10.1371\/journal.pone.0169539","volume":"12","author":"SK Sharma","year":"2017","unstructured":"Sharma SK, Vashishtha R, Chauhan LS, Sreenivas V, Seth D. Comparison of TST and IGRA in diagnosis of latent tuberculosis infection in a high TB-burden setting. PLoS ONE. 2017;12:e0169539.","journal-title":"PLoS ONE"},{"key":"144_CR20","doi-asserted-by":"publisher","first-page":"109132","DOI":"10.1016\/j.clim.2022.109132","volume":"245","author":"G Zhou","year":"2022","unstructured":"Zhou G, Luo Q, Luo S, He J, Chen N, Zhang Y, et al. Positive rates of interferon-\u03b3 release assay and tuberculin skin test in detection of latent tuberculosis infection: a systematic review and meta-analysis of 200,000 head-to-head comparative tests. Clin Immunol. 2022;245:109132.","journal-title":"Clin Immunol"},{"key":"144_CR21","doi-asserted-by":"publisher","first-page":"e1003502","DOI":"10.1371\/journal.pmed.1003502","volume":"18","author":"K Dorjee","year":"2021","unstructured":"Dorjee K, Topgyal S, Tsewang T, Tsundue T, Namdon T, Bonomo E, et al. Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: an impact assessment. PLoS Med. 2021;18:e1003502.","journal-title":"PLoS Med"},{"key":"144_CR22","unstructured":"World Health Organization. Global Tuberculosis Report 2023. 2023. [cited 2024 Jul 19]. Available from: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2023"},{"key":"144_CR23","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.3390\/pathogens11111228","volume":"11","author":"M Coleman","year":"2022","unstructured":"Coleman M, Martinez L, Theron G, Wood R, Marais B. Mycobacterium tuberculosis transmission in high-incidence settings\u2014new paradigms and insights. Pathogens. 2022;11:1228.","journal-title":"Pathogens"},{"key":"144_CR24","doi-asserted-by":"crossref","unstructured":"Mpande CAM, Steigler P, Lloyd T, Rozot V, Mosito B, Schreuder C, et al. Mycobacterium tuberculosis-specific T cell functional, memory, and activation profiles in QuantiFERON-Reverters are consistent with controlled infection. Front Immunol. 2021. [cited 2024 Jul 22];12. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2021.712480\/full","DOI":"10.3389\/fimmu.2021.712480"},{"key":"144_CR25","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1164\/rccm.202007-2686OC","volume":"203","author":"CAM Mpande","year":"2021","unstructured":"Mpande CAM, Musvosvi M, Rozot V, Mosito B, Reid TD, Schreuder C, et al. Antigen-specific T-cell activation distinguishes between recent and remote tuberculosis infection. Am J Respir Crit Care Med. 2021;203:1556\u201365.","journal-title":"Am J Respir Crit Care Med"},{"key":"144_CR26","doi-asserted-by":"publisher","first-page":"e1009197","DOI":"10.1371\/journal.pcbi.1009197","volume":"17","author":"T Lloyd","year":"2021","unstructured":"Lloyd T, Steigler P, Mpande CAM, Rozot V, Mosito B, Schreuder C, et al. Multidimensional analysis of immune responses identified biomarkers of recent Mycobacterium tuberculosis infection. PLoS Comput Biol. 2021;17:e1009197.","journal-title":"PLoS Comput Biol"},{"key":"144_CR27","doi-asserted-by":"publisher","first-page":"7472","DOI":"10.1038\/s41598-020-64428-z","volume":"10","author":"NO Amiano","year":"2020","unstructured":"Amiano NO, Morelli MP, Pellegrini JM, Tateosian NL, Rolandelli A, Seery V, et al. IFN-\u03b3 and IgG responses to Mycobacterium tuberculosis latency antigen Rv2626c differentiate remote from recent tuberculosis infection. Sci Rep. 2020;10:7472.","journal-title":"Sci Rep"},{"key":"144_CR28","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1183\/09031936.00140009","volume":"36","author":"D Goletti","year":"2010","unstructured":"Goletti D, Butera O, Vanini V, Lauria FN, Lange C, Franken KLMC, et al. Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection. Eur Respir J. 2010;36:135\u201342.","journal-title":"Eur Respir J"},{"key":"144_CR29","doi-asserted-by":"publisher","unstructured":"Mendelsohn SC, Andrade BB, Mbandi SK, Andrade AM, Muwanga VM, Figueiredo MC, et al. Transcriptomic signatures of progression to tuberculosis disease among close contacts in Brazil. J Infect Dis. 2024;230(6). https:\/\/doi.org\/10.1093\/infdis\/jiae237.","DOI":"10.1093\/infdis\/jiae237"},{"key":"144_CR30","first-page":"127","volume":"24","author":"A Sakula","year":"1983","unstructured":"Sakula A. Robert Koch: centenary of the discovery of the Tubercle Bacillus, 1882. Can Vet J. 1983;24:127\u201331.","journal-title":"Can Vet J"},{"key":"144_CR31","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1111\/j.1365-3083.1990.tb02919.x","volume":"32","author":"M Harboe","year":"1990","unstructured":"Harboe M, Wiker HG, Lachmann PJ. Carrier effect of concanavalin a-reactive and -non-reactive material in tuberculin PPD. Scand J Immunol. 1990;32:263\u201371.","journal-title":"Scand J Immunol"},{"key":"144_CR32","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/infdis\/148.3.500","volume":"148","author":"Y Ma","year":"1983","unstructured":"Ma Y, Daniel TM. Immunochemical analysis of tuberculin purified protein derivative with special reference to United States-Japan antigen 7. J Infect Dis. 1983;148:500\u20139.","journal-title":"J Infect Dis"},{"key":"144_CR33","doi-asserted-by":"publisher","first-page":"e0190106","DOI":"10.1371\/journal.pone.0190106","volume":"12","author":"M Druszczynska","year":"2017","unstructured":"Druszczynska M, Wlodarczyk M, Kielnierowski G, Seweryn M, Wawrocki S, Rudnicka W. CD14-159C\/T polymorphism in the development of delayed skin hypersensitivity to tuberculin. PLoS ONE. 2017;12:e0190106.","journal-title":"PLoS ONE"},{"key":"144_CR34","doi-asserted-by":"publisher","first-page":"16612","DOI":"10.3390\/ijms242316612","volume":"24","author":"X Guo","year":"2023","unstructured":"Guo X, Du W, Li J, Dong J, Shen X, Su C, et al. A comparative study on the mechanism of delayed-type hypersensitivity mediated by the recombinant mycobacterium tuberculosis fusion protein ESAT6-CFP10 and purified protein derivative. Int J Mol Sci. 2023;24:16612.","journal-title":"Int J Mol Sci"},{"key":"144_CR35","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.ccm.2019.07.007","volume":"40","author":"MK Haas","year":"2019","unstructured":"Haas MK, Belknap RW. Diagnostic tests for latent tuberculosis infection. Clin Chest Med. 2019;40:829\u201337.","journal-title":"Clin Chest Med"},{"key":"144_CR36","first-page":"e39272","volume":"15","author":"AJ Arumairaj","year":"2023","unstructured":"Arumairaj AJ, Park H, Quesada F, Altonen B, Chaudhari S, Mattana J, et al. Determining the need for additional testing with quantiferon TB gold in patients with positive tuberculin skin tests and a history of BCG vaccination. Cureus. 2023;15:e39272.","journal-title":"Cureus"},{"key":"144_CR37","doi-asserted-by":"crossref","unstructured":"Lu P, Ding X, Sun J, Wang R, Liu J, Liu Q, et al. Selection of the cutoff value of the tuberculin skin test for diagnosing students who need preventive treatment: a school-based cross-sectional study. Front Cell Infect Microbiol. 2022;12. [cited 2024 Jul 21]. Available from: https:\/\/www.frontiersin.org\/journals\/cellular-and-infection-microbiology\/articles\/10.3389\/fcimb.2022.972484\/full","DOI":"10.3389\/fcimb.2022.972484"},{"key":"144_CR38","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/crj.13569","volume":"17","author":"JA Santos","year":"2023","unstructured":"Santos JA, Duarte R, Nunes C. Tuberculin skin test and interferon-\u03b3 release assays: Can they agree? Clin Respir J. 2023;17:109\u201314.","journal-title":"Clin Respir J"},{"key":"144_CR39","first-page":"512","volume":"14","author":"I Shah","year":"2021","unstructured":"Shah I, Raut V, Shetty NS. Interpretation of tuberculin skin test in bacillus Calmette\u2013Guerin-vaccinated children. Med J Dr Patil Univ. 2021;14:512.","journal-title":"Med J Dr Patil Univ"},{"key":"144_CR40","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/crj.13166","volume":"14","author":"J Almeida Santos","year":"2020","unstructured":"Almeida Santos J, Duarte R, Nunes C. Tuberculin skin test and predictive host factors for false-negative results in patients with pulmonary and extrapulmonary tuberculosis. Clin Respir J. 2020;14:541\u20138.","journal-title":"Clin Respir J"},{"key":"144_CR41","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.3390\/diagnostics13142369","volume":"13","author":"UD Binay","year":"2023","unstructured":"Binay UD, Kara AV, Karake\u00e7ili F, Barkay O. Diagnosis of latent tuberculosis infection in hemodialysis patients: TST versus T-SPOT.TB. Diagnostics. 2023;13:2369.","journal-title":"Diagnostics."},{"key":"144_CR42","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1186\/s12879-020-05166-5","volume":"20","author":"M-E Hejazi","year":"2020","unstructured":"Hejazi M-E, Ahmadzadeh A, Khabbazi A, Ebrahimi A, Farmani M, Hejazi Y. Tuberculin skin test conversion in patients under treatment with anti-tumor necrotizing factor alpha agents. BMC Infect Dis. 2020;20:464.","journal-title":"BMC Infect Dis"},{"key":"144_CR43","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/S0140-6736(00)02742-2","volume":"356","author":"P Andersen","year":"2000","unstructured":"Andersen P, Munk M, Pollock J, Doherty T. Specific immune-based diagnosis of tuberculosis. Lancet. 2000;356:1099\u2013104.","journal-title":"Lancet"},{"key":"144_CR44","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/iai.64.1.16-22.1996","volume":"64","author":"M Harboe","year":"1996","unstructured":"Harboe M, Oettinger T, Wiker HG, Rosenkrands I, Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun. 1996;64:16\u201322.","journal-title":"Infect Immun"},{"key":"144_CR45","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.resinv.2023.04.010","volume":"61","author":"Y Kobashi","year":"2023","unstructured":"Kobashi Y. Current status and future landscape of diagnosing tuberculosis infection. Respir Investig. 2023;61:563\u201378.","journal-title":"Respir Investig"},{"key":"144_CR46","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1365-3083.2012.02776.x","volume":"76","author":"SY Kim","year":"2012","unstructured":"Kim SY, Park MS, Kim YS, Kim SK, Chang J, Lee HJ, et al. The responses of multiple cytokines following incubation of whole blood from TB patients, latently infected individuals and controls with the TB antigens ESAT-6, CFP-10 and TB7.7. Scand J Immunol. 2012;76:580\u20136.","journal-title":"Scand J Immunol."},{"key":"144_CR47","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1128\/CVI.00132-07","volume":"14","author":"EMS Leyten","year":"2007","unstructured":"Leyten EMS, Arend SM, Prins C, Cobelens FGJ, Ottenhoff THM, van Dissel JT. Discrepancy between mycobacterium tuberculosis-specific gamma interferon release assays using short and prolonged in vitro incubation. Clin Vaccine Immunol CVI. 2007;14:880\u20135.","journal-title":"Clin Vaccine Immunol CVI"},{"key":"144_CR48","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1128\/CVI.00651-13","volume":"21","author":"C Wyndham-Thomas","year":"2014","unstructured":"Wyndham-Thomas C, Corbi\u00e8re V, Dirix V, Smits K, Domont F, Libin M, et al. Key role of effector memory CD4+ T lymphocytes in a short-incubation heparin-binding hemagglutinin gamma interferon release assay for the detection of latent tuberculosis. Clin Vaccine Immunol CVI. 2014;21:321\u20138.","journal-title":"Clin Vaccine Immunol CVI"},{"key":"144_CR49","doi-asserted-by":"crossref","unstructured":"Passos BBS, Ara\u00fajo-Pereira M, Vinhaes CL, Amaral EP, Andrade BB. The role of ESAT-6 in tuberculosis immunopathology. Front Immunol. 2024;15. [cited 2024 Jul 22]. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2024.1383098\/full","DOI":"10.3389\/fimmu.2024.1383098"},{"key":"144_CR50","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1086\/381679","volume":"189","author":"C Aagaard","year":"2004","unstructured":"Aagaard C, Brock I, Olsen A, Ottenhoff THM, Weldingh K, Andersen P. Mapping immune reactivity toward Rv2653 and Rv2654: two novel low-molecular-mass antigens found specifically in the Mycobacterium tuberculosis complex. J Infect Dis. 2004;189:812\u20139.","journal-title":"J Infect Dis"},{"key":"144_CR51","doi-asserted-by":"publisher","first-page":"2379","DOI":"10.1128\/JCM.42.6.2379-2387.2004","volume":"42","author":"I Brock","year":"2004","unstructured":"Brock I, Weldingh K, Leyten EMS, Arend SM, Ravn P, Andersen P. Specific T-cell epitopes for immunoassay-based diagnosis of mycobacterium tuberculosis infection. J Clin Microbiol. 2004;42:2379\u201387.","journal-title":"J Clin Microbiol"},{"key":"144_CR52","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/1471-2334-7-122","volume":"7","author":"IM Adetifa","year":"2007","unstructured":"Adetifa IM, Lugos MD, Hammond A, Jeffries D, Donkor S, Adegbola RA, et al. Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in The Gambia. BMC Infect Dis. 2007;7:122.","journal-title":"BMC Infect Dis"},{"key":"144_CR53","doi-asserted-by":"publisher","first-page":"e2624","DOI":"10.1371\/journal.pone.0002624","volume":"3","author":"T Connell","year":"2008","unstructured":"Connell T, Ritz N, Paxton G, Buttery J, Curtis N, Ranganathan S. A three-way comparison of tuberculin skin testing, QuantiFERON-TB gold and T-SPOT.TB in children. PloS One. 2008;3:e2624.","journal-title":"PloS One."},{"key":"144_CR54","doi-asserted-by":"publisher","first-page":"5882","DOI":"10.1038\/s41598-018-24285-3","volume":"8","author":"F Du","year":"2018","unstructured":"Du F, Xie L, Zhang Y, Gao F, Zhang H, Chen W, et al. Prospective comparison of QFT-GIT and T-SPOT.TB assays for diagnosis of active tuberculosis. Sci Rep. 2018;8:5882.","journal-title":"Sci Rep."},{"key":"144_CR55","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1164\/rccm.200711-1613OC","volume":"177","author":"R Diel","year":"2008","unstructured":"Diel R, Loddenkemper R, Meywald-Walter K, Niemann S, Nienhaus A. Predictive value of a whole blood IFN-\u03b3 assay for the development of active tuberculosis disease after recent infection with mycobacterium tuberculosis. Am J Respir Crit Care Med. 2008;177:1164\u201370.","journal-title":"Am J Respir Crit Care Med"},{"key":"144_CR56","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1186\/s12879-016-1872-9","volume":"16","author":"MJ Gudj\u00f3nsd\u00f3ttir","year":"2016","unstructured":"Gudj\u00f3nsd\u00f3ttir MJ, K\u00f6tz K, Nielsen RS, Wilmar P, Olausson S, Wallmyr D, et al. Relation between BCG vaccine scar and an interferon-gamma release assay in immigrant children with \u201cpositive\u201d tuberculin skin test (\u226510 mm). BMC Infect Dis. 2016;16:540.","journal-title":"BMC Infect Dis"},{"key":"144_CR57","doi-asserted-by":"crossref","unstructured":"Subramonian A, Walter M. Delayed Tuberculin Skin Testing: Rapid Review. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2022. [cited 2024 Jul 29]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK603330\/","DOI":"10.51731\/cjht.2022.456"},{"key":"144_CR58","unstructured":"World Helath Organization. WHO operational handbook on tuberculosis: module 2: screening: systematic screening for tuberculosis disease. 2022 [cited 2024 Aug 1]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240022614"},{"key":"144_CR59","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12890-022-02149-x","volume":"22","author":"J Mahon","year":"2022","unstructured":"Mahon J, Beale S, Holmes H, Arber M, Nikolayevskyy V, Alagna R, et al. A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations. BMC Pulm Med. 2022;22:375.","journal-title":"BMC Pulm Med"},{"key":"144_CR60","doi-asserted-by":"publisher","first-page":"k2738","DOI":"10.1136\/bmj.k2738","volume":"362","author":"MA Behr","year":"2018","unstructured":"Behr MA, Edelstein PH, Ramakrishnan L. Revisiting the timetable of tuberculosis. BMJ. 2018;362:k2738.","journal-title":"BMJ"},{"key":"144_CR61","first-page":"1352","volume":"12","author":"J Landry","year":"2008","unstructured":"Landry J, Menzies D. Preventive chemotherapy. Where has it got us? Where to go next? [State of the art series. Tuberculosis. Edited by I. D. Rusen. Number 2 in the series]. Int J Tuberc Lung Dis. 2008;12:1352\u201364.","journal-title":"Int J Tuberc Lung Dis"},{"key":"144_CR62","doi-asserted-by":"crossref","unstructured":"Carranza C, Pedraza-Sanchez S, de Oyarzabal-Mendez E, Torres M. Diagnosis for Latent Tuberculosis Infection: New Alternatives. Front Immunol. 2020;11 [cited 2024 Aug 2]. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2020.02006\/full","DOI":"10.3389\/fimmu.2020.02006"},{"key":"144_CR63","unstructured":"CDC. Clinical overview of tuberculosis disease. Tuberc. TB. 2024. [cited 2024 Aug 2]. Available from: https:\/\/www.cdc.gov\/tb\/hcp\/clinical-overview\/tuberculosis-disease.html"},{"key":"144_CR64","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1371\/journal.pmed.0040208","volume":"4","author":"M Pai","year":"2007","unstructured":"Pai M, O\u2019Brien R. Serial testing for tuberculosis: can we make sense of T cell assay conversions and reversions? PLoS Med. 2007;4:e208.","journal-title":"PLoS Med"},{"key":"144_CR65","unstructured":"Centre of Disease Control. Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection --- United States, 2010. 2005. [cited 2024 Aug 11]. Available from: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr5905a1.htm"},{"key":"144_CR66","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1164\/rccm.201704-0817OC","volume":"196","author":"E Nemes","year":"2017","unstructured":"Nemes E, Rozot V, Geldenhuys H, Bilek N, Mabwe S, Abrahams D, et al. Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of Mycobacterium tuberculosis Infection. Am J Respir Crit Care Med. 2017;196:638\u201348.","journal-title":"Am J Respir Crit Care Med"},{"key":"144_CR67","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1186\/s12879-020-05483-9","volume":"20","author":"R Sloot","year":"2020","unstructured":"Sloot R, Shanaube K, Claassens M, Telisinghe L, Schaap A, Godfrey-Faussett P, et al. Interpretation of serial interferon-gamma test results to measure new tuberculosis infection among household contacts in Zambia and South Africa. BMC Infect Dis. 2020;20:760.","journal-title":"BMC Infect Dis"},{"key":"144_CR68","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.jinf.2019.01.008","volume":"78","author":"H Zhang","year":"2019","unstructured":"Zhang H, Xin H, Wang D, Pan S, Liu Z, Cao X, et al. Serial testing of Mycobacterium tuberculosis infection in Chinese village doctors by QuantiFERON-TB Gold Plus, QuantiFERON-TB Gold in-Tube and T-SPOT.TB. J Infect. 2019;78:305\u201310.","journal-title":"J Infect."},{"key":"144_CR69","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.3390\/pathogens11111258","volume":"11","author":"N Salazar-Austin","year":"2022","unstructured":"Salazar-Austin N, Mulder C, Hoddinott G, Ryckman T, Hanrahan CF, Velen K, et al. Preventive treatment for household contacts of drug-susceptible tuberculosis patients. Pathogens. 2022;11:1258.","journal-title":"Pathogens"},{"key":"144_CR70","doi-asserted-by":"crossref","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis. Module 1: Prevention. Tuberculosis preventive treatment. Tuberc Lung Dis HIV Infect. 2021;86\u201392.","DOI":"10.30978\/TB2021-2-86"},{"key":"144_CR71","doi-asserted-by":"publisher","first-page":"e0235986","DOI":"10.1371\/journal.pone.0235986","volume":"15","author":"I Casas","year":"2020","unstructured":"Casas I, Esteve M, Guerola R, Latorre I, Villar-Hern\u00e1ndez R, Mena G, et al. Serial testing of health care workers for tuberculosis infection: A prospective cohort study. PLoS ONE. 2020;15:e0235986.","journal-title":"PLoS ONE"},{"key":"144_CR72","doi-asserted-by":"publisher","first-page":"6773","DOI":"10.3390\/ijerph17186773","volume":"17","author":"AR Corvino","year":"2020","unstructured":"Corvino AR, Monaco MGL, Garzillo EM, Grimaldi E, Donnarumma G, Miraglia N, et al. Tuberculosis infection screening in 5468 Italian healthcare students: investigation of a Borderline zone value for the QFT-Test. Int J Environ Res Public Health. 2020;17:6773.","journal-title":"Int J Environ Res Public Health"},{"key":"144_CR73","doi-asserted-by":"crossref","unstructured":"He Y, Cao X, Guo T, He Y, Du Y, Zhang H, et al. Serial testing of latent tuberculosis infection in patients with diabetes mellitus using interferon-gamma release assay, tuberculin skin test, and creation tuberculin skin test. Front Public Health. 2022;10. [cited 2024 Aug 1]. Available from: https:\/\/www.frontiersin.org\/journals\/public-health\/articles\/10.3389\/fpubh.2022.1025550\/full","DOI":"10.3389\/fpubh.2022.1025550"},{"key":"144_CR74","doi-asserted-by":"publisher","first-page":"e0204035","DOI":"10.1371\/journal.pone.0204035","volume":"13","author":"Y Park","year":"2018","unstructured":"Park Y, Kim SY, Kim JW, Park MS, Kim YS, Chang J, et al. Serial testing of healthcare workers for latent tuberculosis infection and long-term follow up for development of active tuberculosis. PLoS ONE. 2018;13:e0204035.","journal-title":"PLoS ONE"},{"key":"144_CR75","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12995-016-0117-6","volume":"11","author":"R Olivieri","year":"2016","unstructured":"Olivieri R, Scarnera S, Ciabattini A, De Vuono G, Manzi P, Pozzi G, et al. Using IFN-gamma release assay to confirm tuberculin skin test improves the screening of latent tuberculosis infection in Italian healthcare workers. J Occup Med Toxicol. 2016;11:29.","journal-title":"J Occup Med Toxicol"},{"key":"144_CR76","doi-asserted-by":"publisher","unstructured":"Kirman JR, Henao-Tamayo MI, Agger EM. The memory immune response to tuberculosis. Microbiol Spectr. 2016;4:https:\/\/doi.org\/10.1128\/microbiolspec.tbtb2-0009-2016.","DOI":"10.1128\/microbiolspec.tbtb2-0009-2016"},{"key":"144_CR77","doi-asserted-by":"crossref","unstructured":"Liu X, Li H, Li S, Yuan J, Pang Y. Maintenance and recall of memory T cell populations against tuberculosis: Implications for vaccine design. Front Immunol. 2023;14. [cited 2024 Jul 29]. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2023.1100741\/full","DOI":"10.3389\/fimmu.2023.1100741"},{"key":"144_CR78","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1186\/s12879-020-05515-4","volume":"20","author":"PGT Cudahy","year":"2020","unstructured":"Cudahy PGT, Wilson D, Cohen T. Risk factors for recurrent tuberculosis after successful treatment in a high burden setting: a cohort study. BMC Infect Dis. 2020;20:789.","journal-title":"BMC Infect Dis"},{"key":"144_CR79","doi-asserted-by":"publisher","first-page":"e965","DOI":"10.1093\/cid\/ciac451","volume":"76","author":"CR Horsburgh","year":"2022","unstructured":"Horsburgh CR, Jo Y, Nichols B, Jenkins HE, Russell CA, White LF. Contribution of reinfection to Annual Rate of tuberculosis Infection (ARI) and incidence of tuberculosis disease. Clin Infect Dis Off Publ Infect Dis Soc Am. 2022;76:e965\u201372.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"144_CR80","doi-asserted-by":"publisher","first-page":"529","DOI":"10.5588\/ijtld.21.0607","volume":"26","author":"PT Pelzer","year":"2022","unstructured":"Pelzer PT, Smit Y, Tiemersma EW, Huong NT, Nhung NV, Cobelens F. Does BCG vaccination protect against infection with M. tuberculosis? Int J Tuberc Lung Dis. 2022;26:529\u201336.","journal-title":"Int J Tuberc Lung Dis."},{"key":"144_CR81","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/S1473-3099(23)00818-6","volume":"24","author":"PCP dos Santos","year":"2024","unstructured":"dos Santos PCP, Messina NL, de Oliveira RD, da Silva PV, Puga MAM, Dalcolmo M, et al. Effect of BCG vaccination against Mycobacterium tuberculosis infection in adult Brazilian health-care workers: a nested clinical trial. Lancet Infect Dis. 2024;24:594\u2013601.","journal-title":"Lancet Infect Dis"},{"key":"144_CR82","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/imcb.12278","volume":"97","author":"P Steigler","year":"2019","unstructured":"Steigler P, Verrall AJ, Kirman JR. Beyond memory T cells: mechanisms of protective immunity to tuberculosis infection. Immunol Cell Biol. 2019;97:647\u201355.","journal-title":"Immunol Cell Biol"},{"key":"144_CR83","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1615\/CritRevImmunol.2014010373","volume":"34","author":"DJ Gasper","year":"2014","unstructured":"Gasper DJ, Tejera MM, Suresh M. CD4 T-cell memory generation and maintenance. Crit Rev Immunol. 2014;34:121\u201346.","journal-title":"Crit Rev Immunol"},{"key":"144_CR84","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.imlet.2006.08.002","volume":"107","author":"M Vukmanovic-Stejic","year":"2006","unstructured":"Vukmanovic-Stejic M, Reed JR, Lacy KE, Rustin MHA, Akbar AN. Mantoux Test as a model for a secondary immune response in humans. Immunol Lett. 2006;107:93\u2013101.","journal-title":"Immunol Lett"},{"key":"144_CR85","doi-asserted-by":"publisher","first-page":"1949","DOI":"10.3201\/eid2510.190439","volume":"25","author":"LA Vonnahme","year":"2019","unstructured":"Vonnahme LA, Haddad MB, Navin TR. Factoring prior treatment into tuberculosis infection prevalence estimates, United States, 2011\u20132012. Emerg Infect Dis. 2019;25:1949\u201351.","journal-title":"Emerg Infect Dis"},{"key":"144_CR86","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1001\/jama.1971.03190250021005","volume":"218","author":"NO Atuk","year":"1971","unstructured":"Atuk NO, Hunt EH. Serial tuberculin testing and isoniazid therapy in general hospital employees. JAMA. 1971;218:1795\u20138.","journal-title":"JAMA"},{"key":"144_CR87","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/00039896.1968.10665013","volume":"16","author":"VN Houk","year":"1968","unstructured":"Houk VN, Kent DC, Sorensen K, Baker JH. The eradication of tuberculosis infection by isoniazid chemoprophylaxis. Arch Environ Health Int J. 1968;16:46\u201350.","journal-title":"Arch Environ Health Int J"},{"key":"144_CR88","doi-asserted-by":"publisher","first-page":"l5770","DOI":"10.1136\/bmj.l5770","volume":"367","author":"MA Behr","year":"2019","unstructured":"Behr MA, Edelstein PH, Ramakrishnan L. Is mycobacterium tuberculosis infection life long? BMJ. 2019;367:l5770.","journal-title":"BMJ"},{"key":"144_CR89","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","volume":"159","author":"D Menzies","year":"1999","unstructured":"Menzies D. Interpretation of repeated tuberculin tests. Am J Respir Crit Care Med. 1999;159:15\u201321.","journal-title":"Am J Respir Crit Care Med"},{"key":"144_CR90","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jinf.2018.04.009","volume":"77","author":"H Zhang","year":"2018","unstructured":"Zhang H, Xin H, Li X, Li H, Li M, Feng B, et al. Reversion of QuantiFERON-TB gold in-tube test in individuals with and without prophylactic treatment for latent tuberculosis infection: a systematic review and meta-analysis. J Infect. 2018;77:276\u201382.","journal-title":"J Infect"},{"key":"144_CR91","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1086\/427030","volume":"40","author":"PC Hill","year":"2005","unstructured":"Hill PC, Fox A, Jeffries DJ, Jackson-Sillah D, Lugos MD, Owiafe PK, et al. Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;40:273\u20138.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"144_CR92","doi-asserted-by":"crossref","unstructured":"Rodr\u00edguez-Molino P, Gonz\u00e1lez S\u00e1nchez A, Noguera-Juli\u00e1n A, Soler-Garc\u00eda A, Mart\u00ednez Paz P, M\u00e9ndez-Echevarr\u00eda A, et al. QuantiFERON-TB reversion in children and adolescents with tuberculosis. Front Immunol. 2024;15. [cited 2024 Aug 1]. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2024.1310472\/full","DOI":"10.3389\/fimmu.2024.1310472"},{"key":"144_CR93","doi-asserted-by":"publisher","first-page":"1555.e1","DOI":"10.1016\/j.cmi.2020.02.009","volume":"26","author":"H Xin","year":"2020","unstructured":"Xin H, Cao X, Zhang H, Liu J, Pan S, Li X, et al. Dynamic changes of interferon gamma release assay results with latent tuberculosis infection treatment. Clin Microbiol Infect. 2020;26:1555.e1-1555.e7.","journal-title":"Clin Microbiol Infect"},{"key":"144_CR94","doi-asserted-by":"publisher","first-page":"e0235254","DOI":"10.1371\/journal.pone.0235254","volume":"15","author":"JH Park","year":"2020","unstructured":"Park JH, Kim N, Park H, Kim TS, Park S-W, Roh EY, et al. The use of a borderline zone for the interpretation of interferon-gamma release assay results for serial screening of healthcare workers. PLoS ONE. 2020;15:e0235254.","journal-title":"PLoS ONE"},{"key":"144_CR95","doi-asserted-by":"publisher","unstructured":"Wikell A, Jonsson J, Dyrdak R, Henningsson AJ, Eringf\u00e4lt A, Kjerstadius T, et al. The impact of borderline quantiferon-TB gold plus results for latent tuberculosis screening under routine conditions in a low-endemicity setting. J Clin Microbiol. 2021;59:https:\/\/doi.org\/10.1128\/jcm.01370-21.","DOI":"10.1128\/jcm.01370-21"},{"key":"144_CR96","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.dsi.2014.12.005","volume":"33","author":"C-Y Cheng","year":"2015","unstructured":"Cheng C-Y, Hui RC-Y, Hu S, Hsieh M-H, Huang Y-H. Serial QuantiFERON-TB Gold In-Tube testing for psoriatic patients receiving antitumor necrosis factor-alpha therapy. Dermatol Sin. 2015;33:124\u20139.","journal-title":"Dermatol Sin."},{"key":"144_CR97","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1620\/tjem.233.123","volume":"233","author":"KW Seo","year":"2014","unstructured":"Seo KW, Ahn J-J, Ra SW, Kwon W-J, Jegal Y. Persistently retained interferon-gamma responsiveness in individuals with a history of pulmonary tuberculosis. Tohoku J Exp Med. 2014;233:123\u20138.","journal-title":"Tohoku J Exp Med"},{"key":"144_CR98","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1183\/09031936.00151309","volume":"36","author":"CBE Chee","year":"2010","unstructured":"Chee CBE, Khinmar KW, Gan SH, Barkham TM, Koh CK, Shen L, et al. Tuberculosis treatment effect on T-cell interferon-\u03b3 responses to Mycobacterium tuberculosis-specific antigens. Eur Respir J. 2010;36:355\u201361.","journal-title":"Eur Respir J"},{"key":"144_CR99","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1086\/381763","volume":"38","author":"A Lalvani","year":"2004","unstructured":"Lalvani A. Counting antigen-specific T cells: a new approach for monitoring response to tuberculosis treatment? Clin Infect Dis. 2004;38:757\u20139.","journal-title":"Clin Infect Dis"},{"key":"144_CR100","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1745-6673-1-7","volume":"1","author":"M Pai","year":"2006","unstructured":"Pai M, Joshi R, Dogra S, Mendiratta DK, Narang P, Dheda K, et al. Persistently elevated T cell interferon-\u03b3 responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report. J Occup Med Toxicol Lond Engl. 2006;1:7.","journal-title":"J Occup Med Toxicol Lond Engl"},{"key":"144_CR101","doi-asserted-by":"publisher","first-page":"757152","DOI":"10.1155\/2012\/757152","volume":"2012","author":"I Takenami","year":"2012","unstructured":"Takenami I, Finkmoore B, Machado A, Emodi K, Riley LW, Arruda S. Levels of interferon-gamma increase after treatment for latent tuberculosis infection in a high-transmission setting. Pulm Med. 2012;2012:757152.","journal-title":"Pulm Med"},{"key":"144_CR102","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1016\/j.jiph.2023.07.001","volume":"16","author":"T Abdul-Rahman","year":"2023","unstructured":"Abdul-Rahman T, Ghosh S, Lukman L, Bamigbade GB, Oladipo OV, Amarachi OR, et al. Inaccessibility and low maintenance of medical data archive in low-middle income countries: Mystery behind public health statistics and measures. J Infect Public Health. 2023;16:1556\u201361.","journal-title":"J Infect Public Health"},{"key":"144_CR103","doi-asserted-by":"publisher","first-page":"e259","DOI":"10.1016\/S2468-2667(22)00001-9","volume":"7","author":"AD Hossain","year":"2022","unstructured":"Hossain AD, Jarolimova J, Elnaiem A, Huang CX, Richterman A, Ivers LC. Effectiveness of contact tracing in the control of infectious diseases: a systematic review. Lancet Public Health. 2022;7:e259\u201373.","journal-title":"Lancet Public Health"},{"key":"144_CR104","unstructured":"Baxter S, Goyder E, Chambers D, Johnson M, Preston L, Booth A. Background. Interv Improve Contact Tracing Tuberc Specif Groups Wider Popul Evid Synth. NIHR Journals Library; 2017 [cited 2024 Aug 6]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK409247\/"},{"key":"144_CR105","unstructured":"World Health Organization. Recommendations for Investigating Contacts of Persons with Infectious Tuberculosis in Low- and Middle-Income Countries [Internet]. Geneva: World Health Organization; 2012 [cited 2024 Aug 6]. Available from: http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK179062\/"},{"key":"144_CR106","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40249-022-00965-1","volume":"11","author":"BT Shaikh","year":"2022","unstructured":"Shaikh BT, Laghari AK, Durrani S, Chaudhry A, Ali N. Supporting tuberculosis program in active contact tracing: a case study from Pakistan. Infect Dis Poverty. 2022;11:42.","journal-title":"Infect Dis Poverty"},{"key":"144_CR107","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1016\/S0140-6736(15)00322-0","volume":"386","author":"CM Yuen","year":"2015","unstructured":"Yuen CM, Amanullah F, Dharmadhikari A, Nardell EA, Seddon JA, Vasilyeva I, et al. Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment. The Lancet. 2015;386:2334\u201343.","journal-title":"The Lancet"},{"key":"144_CR108","unstructured":"Centre of Disease Control. Self-study modules on tuberculosis module 8 contact investigations for tuberculosis. 2014"},{"key":"144_CR109","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1183\/09031936.00104108","volume":"33","author":"CC Dobler","year":"2009","unstructured":"Dobler CC, Crawford ABH, Jelfs PJ, Gilbert GL, Marks GB. Recurrence of tuberculosis in a low-incidence setting. Eur Respir J. 2009;33:160\u20137.","journal-title":"Eur Respir J"},{"key":"144_CR110","doi-asserted-by":"publisher","first-page":"S644","DOI":"10.1093\/infdis\/jix354","volume":"216","author":"B Mathema","year":"2017","unstructured":"Mathema B, Andrews JR, Cohen T, Borgdorff MW, Behr M, Glynn JR, et al. Drivers of tuberculosis transmission. J Infect Dis. 2017;216:S644\u201353.","journal-title":"J Infect Dis"},{"key":"144_CR111","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/tmi.13808","volume":"27","author":"KD Sagili","year":"2022","unstructured":"Sagili KD, Muniyandi M, Shringarpure K, Singh K, Kirubakaran R, Rao R, et al. Strategies to detect and manage latent tuberculosis infection among household contacts of pulmonary TB patients in high TB burden countries - a systematic review and meta-analysis. Trop Med Int Health. 2022;27:842\u201363.","journal-title":"Trop Med Int Health"},{"key":"144_CR112","doi-asserted-by":"publisher","first-page":"4784","DOI":"10.3390\/jcm12144784","volume":"12","author":"R Cioboata","year":"2023","unstructured":"Cioboata R, Biciusca V, Olteanu M, Vasile CM. COVID-19 and tuberculosis: unveiling the dual threat and shared solutions perspective. J Clin Med. 2023;12:4784.","journal-title":"J Clin Med"},{"key":"144_CR113","doi-asserted-by":"crossref","unstructured":"Dass SA, Balakrishnan V, Arifin N, Lim CSY, Nordin F, Tye GJ. The COVID-19\/tuberculosis syndemic and potential antibody therapy for TB based on the lessons learnt from the pandemic. Front Immunol. 2022;13. [cited 2024 Aug 9]. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2022.833715\/full","DOI":"10.3389\/fimmu.2022.833715"},{"key":"144_CR114","doi-asserted-by":"publisher","first-page":"e1323","DOI":"10.1016\/S2214-109X(23)00360-1","volume":"11","author":"HH Kyu","year":"2023","unstructured":"Kyu HH, Ledesma JR. What is the impact of the COVID-19 pandemic on tuberculosis? Lancet Glob Health. 2023;11:e1323\u20134.","journal-title":"Lancet Glob Health"},{"key":"144_CR115","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/tropicalmed9010007","volume":"9","author":"P Mahajan","year":"2024","unstructured":"Mahajan P, Soundappan K, Singla N, Mehta K, Nuken A, Thekkur P, et al. Test and treat model for tuberculosis preventive treatment among household contacts of pulmonary tuberculosis patients in selected districts of Maharashtra: a mixed-methods study on care cascade, timeliness, and early implementation challenges. Trop Med Infect Dis. 2024;9:7.","journal-title":"Trop Med Infect Dis"},{"key":"144_CR116","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.ijid.2023.02.016","volume":"130","author":"A Matteelli","year":"2023","unstructured":"Matteelli A, Lovatti S, Sforza A, Rossi L. Programmatic management of tuberculosis preventive therapy: past, present, future. Int J Infect Dis. 2023;130:S43\u20136.","journal-title":"Int J Infect Dis"},{"key":"144_CR117","first-page":"49","volume":"6","author":"J Campbell","year":"2022","unstructured":"Campbell J, Pease C, Daley P, Pai M, Menzies D. Chapter 4: Diagnosis of tuberculosis infection. Can J Respir Crit Care Sleep Med. 2022;6:49\u201365.","journal-title":"Can J Respir Crit Care Sleep Med."},{"key":"144_CR118","doi-asserted-by":"crossref","unstructured":"Bhargava A. The 3 HP regimen for tuberculosis preventive treatment: safety, dosage and related concerns during its large-scale implementation in countries like India. Lancet Reg Health - Southeast Asia. 2024;0. [cited 2024 Aug 5]. Available from: https:\/\/www.thelancet.com\/journals\/lansea\/article\/PIIS2772-3682(24)00072-6\/fulltext","DOI":"10.1016\/j.lansea.2024.100422"},{"key":"144_CR119","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1093\/cid\/ciad246","volume":"77","author":"L Melnychuk","year":"2023","unstructured":"Melnychuk L, Perlman-Arrow S, Lisboa Bastos M, Menzies D. A systematic review and meta-analysis of tuberculous preventative therapy adverse events. Clin Infect Dis Off Publ Infect Dis Soc Am. 2023;77:287\u201394.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"144_CR120","doi-asserted-by":"crossref","unstructured":"Jo Y, Gomes I, Flack J, Salazar-Austin N, Churchyard G, Chaisson RE, et al. Cost-effectiveness of scaling up short course preventive therapy for tuberculosis among children across 12 countries. eClinicalMedicine. 2021;31. [cited 2024 Aug 6]. Available from: https:\/\/www.thelancet.com\/journals\/eclinm\/article\/PIIS2589-5370(20)30451-X\/fulltext","DOI":"10.1016\/j.eclinm.2020.100707"},{"key":"144_CR121","doi-asserted-by":"publisher","first-page":"e1205","DOI":"10.1016\/S2214-109X(23)00251-6","volume":"11","author":"T Ryckman","year":"2023","unstructured":"Ryckman T, Weiser J, Gombe M, Turner K, Soni P, Tarlton D, et al. Impact and cost-effectiveness of short-course tuberculosis preventive treatment for household contacts and people with HIV in 29 high-incidence countries: a modelling analysis. Lancet Glob Health. 2023;11:e1205\u201316.","journal-title":"Lancet Glob Health"},{"key":"144_CR122","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3390\/tropicalmed8040214","volume":"8","author":"S Satyanarayana","year":"2023","unstructured":"Satyanarayana S, Pretorius C, Kanchar A, Garcia Baena I, Den Boon S, Miller C, et al. Scaling Up TB screening and TB preventive treatment globally: key actions and healthcare service costs. Trop Med Infect Dis. 2023;8:214.","journal-title":"Trop Med Infect Dis"},{"key":"144_CR123","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1038\/emi.2016.10","volume":"5","author":"J-W Ai","year":"2016","unstructured":"Ai J-W, Ruan Q-L, Liu Q-H, Zhang W-H. Updates on the risk factors for latent tuberculosis reactivation and their managements. Emerg Microbes Infect. 2016;5:e10.","journal-title":"Emerg Microbes Infect"},{"key":"144_CR124","doi-asserted-by":"publisher","first-page":"e0285534","DOI":"10.1371\/journal.pone.0285534","volume":"18","author":"MMD Goroh","year":"2023","unstructured":"Goroh MMD, van den Boogaard CHA, Lukman KA, Lowbridge C, Juin WK, William T, et al. Factors affecting implementation of tuberculosis contact investigation and tuberculosis preventive therapy among children in Sabah, East Malaysia: a qualitative study. PLoS ONE. 2023;18:e0285534.","journal-title":"PLoS ONE"},{"key":"144_CR125","doi-asserted-by":"publisher","first-page":"596","DOI":"10.5588\/ijtld.17.0758","volume":"22","author":"I Pathmanathan","year":"2018","unstructured":"Pathmanathan I, Ahmedov S, Pevzner E, Anyalechi G, Modi S, Kirking H, et al. TB Preventive therapy for people living with HIV \u2013 key considerations for scale-up in resource-limited settings. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2018;22:596\u2013605.","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"144_CR126","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.5588\/ijtld.16.0471","volume":"21","author":"DG Datiko","year":"2017","unstructured":"Datiko DG, Yassin MA, Theobald SJ, Cuevas LE. A community-based isoniazid preventive therapy for the prevention of childhood tuberculosis in Ethiopia. Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis. 2017;21:1002\u20137.","journal-title":"Int J Tuberc Lung Dis Off J Int Union Tuberc Lung Dis"},{"key":"144_CR127","doi-asserted-by":"publisher","first-page":"1979281","DOI":"10.1080\/16549716.2021.1979281","volume":"14","author":"AA Ahmed","year":"2021","unstructured":"Ahmed AA, Grammatico M, Moll AP, Malinga S, Makhunga P, Charalambous S, et al. Factors associated with low tuberculosis preventive therapy prescription rates among health care workers in rural South Africa. Glob Health Action. 2021;14:1979281.","journal-title":"Glob Health Action"},{"key":"144_CR128","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/s11274-023-03636-x","volume":"39","author":"ML Carabal\u00ed-Isajar","year":"2023","unstructured":"Carabal\u00ed-Isajar ML, Rodr\u00edguez-Bejarano OH, Amado T, Patarroyo MA, Izquierdo MA, Lutz JR, et al. Clinical manifestations and immune response to tuberculosis. World J Microbiol Biotechnol. 2023;39:206.","journal-title":"World J Microbiol Biotechnol"},{"key":"144_CR129","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.apm.2019.11.013","volume":"80","author":"NK-DO Opoku","year":"2020","unstructured":"Opoku NK-DO, Mazandu GK. Modelling the human immune response dynamics during progression from Mycobacterium latent infection to disease. Appl Math Model. 2020;80:217\u201337.","journal-title":"Appl Math Model."},{"key":"144_CR130","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nri2960","volume":"11","author":"G Walzl","year":"2011","unstructured":"Walzl G, Ronacher K, Hanekom W, Scriba TJ, Zumla A. Immunological biomarkers of tuberculosis. Nat Rev Immunol. 2011;11:343\u201354.","journal-title":"Nat Rev Immunol"},{"key":"144_CR131","doi-asserted-by":"publisher","first-page":"1108155","DOI":"10.3389\/fcimb.2023.1108155","volume":"13","author":"VTA Thu","year":"2023","unstructured":"Thu VTA, Dat LD, Jayanti RP, Trinh HKT, Hung TM, Cho Y-S, et al. Advancing personalized medicine for tuberculosis through the application of immune profiling. Front Cell Infect Microbiol. 2023;13:1108155.","journal-title":"Front Cell Infect Microbiol"},{"issue":"178","key":"144_CR132","first-page":"5217","volume":"2007","author":"KA Millington","year":"1950","unstructured":"Millington KA, Innes JA, Hackforth S, Hinks TSC, Deeks JJ, Dosanjh DPS, et al. Dynamic relationship between IFN-\u03b3 and IL-2 profile of Mycobacterium tuberculosis-specific T cells and antigen load. J Immunol Baltim Md. 1950;2007(178):5217\u201326.","journal-title":"J Immunol Baltim Md"},{"key":"144_CR133","doi-asserted-by":"publisher","first-page":"e11670","DOI":"10.1371\/journal.pone.0011670","volume":"5","author":"B Krummel","year":"2010","unstructured":"Krummel B, Strassburg A, Ernst M, Reiling N, Eker B, Rath H, et al. Potential role for IL-2 ELISpot in differentiating recent and remote infection in tuberculosis contact tracing. PLoS ONE. 2010;5:e11670.","journal-title":"PLoS ONE"},{"key":"144_CR134","doi-asserted-by":"publisher","first-page":"101959","DOI":"10.1016\/j.tube.2020.101959","volume":"123","author":"EW Borgstr\u00f6m","year":"2020","unstructured":"Borgstr\u00f6m EW, Fr\u00f6berg G, Correia-Neves M, Atterfelt FB, Bellbrant J, Szulkin R, et al. CD4+ T cell proliferative responses to PPD and CFP-10 associate with recent M. tuberculosis infection. Tuberculosis. 2020;123:101959.","journal-title":"Tuberculosis."},{"key":"144_CR135","doi-asserted-by":"publisher","first-page":"e136222","DOI":"10.1172\/JCI136222","volume":"131","author":"WH Boom","year":"2021","unstructured":"Boom WH, Schaible UE, Achkar JM. The knowns and unknowns of latent Mycobacterium tuberculosis infection. J Clin Invest. 2021;131:e136222.","journal-title":"J Clin Invest"},{"key":"144_CR136","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3389\/fped.2019.00350","volume":"7","author":"M de Martino","year":"2019","unstructured":"de Martino M, Lodi L, Galli L, Chiappini E. Immune response to mycobacterium tuberculosis: a narrative review. Front Pediatr. 2019;7:350.","journal-title":"Front Pediatr"},{"key":"144_CR137","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41385-020-0322-6","volume":"14","author":"E Du Bruyn","year":"2021","unstructured":"Du Bruyn E, Ruzive S, Lindestam Arlehamn CS, Sette A, Sher A, Barber DL, et al. Mycobacterium tuberculosis-specific CD4 T cells expressing CD153 inversely associate with bacterial load and disease severity in human tuberculosis. Mucosal Immunol. 2021;14:491\u20139.","journal-title":"Mucosal Immunol"},{"key":"144_CR138","doi-asserted-by":"publisher","first-page":"a018465","DOI":"10.1101\/cshperspect.a018465","volume":"4","author":"CS Lindestam Arlehamn","year":"2014","unstructured":"Lindestam Arlehamn CS, Lewinsohn D, Sette A, Lewinsohn D. Antigens for CD4 and CD8 T cells in tuberculosis. Cold Spring Harb Perspect Med. 2014;4:a018465.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"144_CR139","doi-asserted-by":"crossref","unstructured":"Bromley JD, Ganchua SKC, Nyquist SK, Maiello P, Chao M, Borish HJ, et al. CD4+ T cells are homeostatic regulators during Mtb reinfection. bioRxiv. 2023;2023.12.20.572669.","DOI":"10.1101\/2023.12.20.572669"},{"key":"144_CR140","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.jinf.2015.07.009","volume":"71","author":"E Petruccioli","year":"2015","unstructured":"Petruccioli E, Petrone L, Vanini V, Cuzzi G, Navarra A, Gualano G, et al. Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis. J Infect. 2015;71:526\u201333.","journal-title":"J Infect"},{"key":"144_CR141","doi-asserted-by":"publisher","first-page":"e1176","DOI":"10.1002\/cti2.1176","volume":"9","author":"C Riou","year":"2020","unstructured":"Riou C, Du Bruyn E, Ruzive S, Goliath RT, Lindestam Arlehamn CS, Sette A, et al. Disease extent and anti-tubercular treatment response correlates with Mycobacterium tuberculosis-specific CD4 T-cell phenotype regardless of HIV-1 status. Clin Transl Immunol. 2020;9:e1176.","journal-title":"Clin Transl Immunol"},{"key":"144_CR142","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1093\/cid\/ciu795","volume":"60","author":"V Rozot","year":"2015","unstructured":"Rozot V, Patrizia A, Vigano S, Mazza-Stalder J, Idrizi E, Day CL, et al. Combined use of mycobacterium tuberculosis\u2013Specific CD4 and CD8 T-cell responses is a powerful diagnostic tool of active tuberculosis. Clin Infect Dis. 2015;60:432\u20137.","journal-title":"Clin Infect Dis"},{"key":"144_CR143","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1093\/infdis\/jix107","volume":"215","author":"A Halliday","year":"2017","unstructured":"Halliday A, Whitworth H, Kottoor SH, Niazi U, Menzies S, Kunst H, et al. Stratification of latent mycobacterium tuberculosis infection by cellular immune profiling. J Infect Dis. 2017;215:1480\u20137.","journal-title":"J Infect Dis"},{"key":"144_CR144","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00281-015-0490-8","volume":"37","author":"PL Lin","year":"2015","unstructured":"Lin PL, Flynn JL. CD8 T cells and mycobacterium tuberculosis infection. Semin Immunopathol. 2015;37:239\u201349.","journal-title":"Semin Immunopathol"},{"key":"144_CR145","doi-asserted-by":"publisher","first-page":"955","DOI":"10.3390\/vaccines11050955","volume":"11","author":"P Stewart","year":"2023","unstructured":"Stewart P, Patel S, Comer A, Muneer S, Nawaz U, Quann V, et al. Role of B cells in mycobacterium tuberculosis infection. Vaccines. 2023;11:955.","journal-title":"Vaccines"},{"key":"144_CR146","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1164\/rccm.200306-837OC","volume":"168","author":"DA Lewinsohn","year":"2003","unstructured":"Lewinsohn DA, Heinzel AS, Gardner JM, Zhu L, Alderson MR, Lewinsohn DM. Mycobacterium tuberculosis\u2013specific CD8+ T cells preferentially recognize heavily infected cells. Am J Respir Crit Care Med. 2003;168:1346\u201352.","journal-title":"Am J Respir Crit Care Med"},{"key":"144_CR147","doi-asserted-by":"crossref","unstructured":"Sharan R, Singh DK, Rengarajan J, Kaushal D. Characterizing early T cell responses in nonhuman primate model of tuberculosis. Front Immunol. 2021;12. [cited 2024 Aug 16]. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2021.706723\/full","DOI":"10.3389\/fimmu.2021.706723"},{"key":"144_CR148","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1183\/13993003.00510-2016","volume":"48","author":"L Barcellini","year":"2016","unstructured":"Barcellini L, Borroni E, Brown J, Brunetti E, Campisi D, Castellotti PF, et al. First evaluation of QuantiFERON-TB Gold Plus performance in contact screening. Eur Respir J. 2016;48:1411\u20139.","journal-title":"Eur Respir J"},{"key":"144_CR149","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.diagmicrobio.2012.11.023","volume":"75","author":"M Nikolova","year":"2013","unstructured":"Nikolova M, Markova R, Drenska R, Muhtarova M, Todorova Y, Dimitrov V, et al. Antigen-specific CD4- and CD8-positive signatures in different phases of Mycobacterium tuberculosis infection. Diagn Microbiol Infect Dis. 2013;75:277\u201381.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"144_CR150","doi-asserted-by":"publisher","first-page":"106508","DOI":"10.1016\/j.rmed.2021.106508","volume":"185","author":"F Viana Machado","year":"2021","unstructured":"Viana Machado F, Morais C, Santos S, Reis R. Evaluation of CD8+ response in QuantiFERON-TB Gold Plus as a marker of recent infection. Respir Med. 2021;185:106508.","journal-title":"Respir Med"},{"key":"144_CR151","doi-asserted-by":"publisher","first-page":"e0003182","DOI":"10.1371\/journal.pgph.0003182","volume":"4","author":"M Amofa-Sekyi","year":"2024","unstructured":"Amofa-Sekyi M, Schaap A, Mureithi L, Kosloff B, Cheeba M, Kangololo B, et al. Comparing patterns of recent and remote Mycobacterium tuberculosis infection determined using the QuantiFERON-TB Gold Plus assay in a high TB burden setting. PLOS Glob Public Health. 2024;4:e0003182.","journal-title":"PLOS Glob Public Health"},{"key":"144_CR152","doi-asserted-by":"publisher","first-page":"e00972","DOI":"10.1128\/Spectrum.00972-21","volume":"9","author":"S P\u00e9rez-Recio","year":"2021","unstructured":"P\u00e9rez-Recio S, Pallar\u00e8s N, Grijota-Camino MD, S\u00e1nchez-Montalv\u00e1 A, Barcia L, Campos-Guti\u00e9rrez S, et al. Identification of recent tuberculosis exposure using QuantiFERON-TB Gold Plus, a multicenter study. Microbiol Spectr. 2021;9:e00972-e1021.","journal-title":"Microbiol Spectr"},{"key":"144_CR153","doi-asserted-by":"crossref","unstructured":"Lancioni C, Swarbrick GM, Park B, Nyendak M, Nsereko M, Mayanja-Kizza H, et al. Recognition of CD8+ T-cell epitopes to identify adults with pulmonary tuberculosis. Eur Respir J. 2019;53. [cited 2024 Oct 12]. Available from: https:\/\/erj.ersjournals.com\/content\/53\/5\/1802053","DOI":"10.1183\/13993003.02053-2018"},{"key":"144_CR154","first-page":"58","volume":"10","author":"L-S Li","year":"2023","unstructured":"Li L-S, Yang L, Zhuang L, Ye Z-Y, Zhao W-G, Gong W-P. From immunology to artificial intelligence: revolutionizing latent tuberculosis infection diagnosis with machine learning. Mil Med Res. 2023;10:58.","journal-title":"Mil Med Res"},{"key":"144_CR155","doi-asserted-by":"publisher","first-page":"5825","DOI":"10.3390\/cimb46060348","volume":"46","author":"Y Liu","year":"2024","unstructured":"Liu Y, Li H, Dai D, He J, Liang Z. Gene regulatory mechanism of mycobacterium tuberculosis during dormancy. Curr Issues Mol Biol. 2024;46:5825\u201344.","journal-title":"Curr Issues Mol Biol"},{"key":"144_CR156","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3390\/toxins6031002","volume":"6","author":"A Sala","year":"2014","unstructured":"Sala A, Bordes P, Genevaux P. Multiple toxin-antitoxin systems in mycobacterium tuberculosis. Toxins. 2014;6:1002\u201320.","journal-title":"Toxins"},{"key":"144_CR157","doi-asserted-by":"publisher","first-page":"e5590","DOI":"10.1371\/journal.pone.0005590","volume":"4","author":"SD Schuck","year":"2009","unstructured":"Schuck SD, Mueller H, Kunitz F, Neher A, Hoffmann H, Franken KLCM, et al. Identification of T-cell antigens specific for latent mycobacterium tuberculosis infection. PLoS ONE. 2009;4:e5590.","journal-title":"PLoS ONE"},{"key":"144_CR158","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1186\/s12879-020-05194-1","volume":"20","author":"W van Loon","year":"2020","unstructured":"van Loon W, Gomez MP, Jobe D, Franken KLMC, Ottenhoff THM, Coninx M, et al. Use of resuscitation promoting factors to screen for tuberculosis infection in household-exposed children in The Gambia. BMC Infect Dis. 2020;20:469.","journal-title":"BMC Infect Dis"},{"key":"144_CR159","doi-asserted-by":"publisher","first-page":"6760","DOI":"10.1128\/JB.184.24.6760-6767.2002","volume":"184","author":"C Boon","year":"2002","unstructured":"Boon C, Dick T. Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. J Bacteriol. 2002;184:6760\u20137.","journal-title":"J Bacteriol"},{"key":"144_CR160","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1128\/JB.00926-09","volume":"192","author":"RL Leistikow","year":"2010","unstructured":"Leistikow RL, Morton RA, Bartek IL, Frimpong I, Wagner K, Voskuil MI. The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy. J Bacteriol. 2010;192:1662\u201370.","journal-title":"J Bacteriol"},{"key":"144_CR161","doi-asserted-by":"crossref","unstructured":"Meier NR, Jacobsen M, Ottenhoff THM, Ritz N. A systematic review on novel mycobacterium tuberculosis antigens and their discriminatory potential for the diagnosis of latent and active tuberculosis. Front Immunol. 2018;9. [cited 2024 Aug 16]. Available from: https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2018.02476\/full","DOI":"10.3389\/fimmu.2018.02476"},{"key":"144_CR162","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.jinf.2020.11.032","volume":"82","author":"E Adankwah","year":"2021","unstructured":"Adankwah E, Nausch N, Minadzi D, Abass MK, Franken KLMC, Ottenhoff THM, et al. Interleukin-6 and Mycobacterium tuberculosis dormancy antigens improve diagnosis of tuberculosis. J Infect. 2021;82:245\u201352.","journal-title":"J Infect"},{"key":"144_CR163","doi-asserted-by":"publisher","first-page":"e38501","DOI":"10.1371\/journal.pone.0038501","volume":"7","author":"NN Chegou","year":"2012","unstructured":"Chegou NN, Essone PN, Loxton AG, Stanley K, Black GF, van der Spuy GD, et al. Potential of host markers produced by infection phase-dependent antigen-stimulated cells for the diagnosis of tuberculosis in a highly endemic area. PLoS ONE. 2012;7:e38501.","journal-title":"PLoS ONE"},{"key":"144_CR164","doi-asserted-by":"publisher","first-page":"17684","DOI":"10.1038\/s41598-022-20409-y","volume":"12","author":"P Bachanov\u00e1","year":"2022","unstructured":"Bachanov\u00e1 P, Cheyne A, Broderick C, Newton SM, Levin M, Kaforou M. Comparative transcriptomic analysis of whole blood mycobacterial growth assays and tuberculosis patients\u2019 blood RNA profiles. Sci Rep. 2022;12:17684.","journal-title":"Sci Rep"},{"key":"144_CR165","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s41590-018-0225-9","volume":"19","author":"A Singhania","year":"2018","unstructured":"Singhania A, Wilkinson RJ, Rodrigue M, Haldar P, O\u2019Garra A. Transcriptomics in TB: the immune response and diagnosis. Nat Immunol. 2018;19:1159\u201368.","journal-title":"Nat Immunol"},{"key":"144_CR166","doi-asserted-by":"publisher","first-page":"e20210915","DOI":"10.1084\/jem.20210915","volume":"218","author":"O Tabone","year":"2021","unstructured":"Tabone O, Verma R, Singhania A, Chakravarty P, Branchett WJ, Graham CM, et al. Blood transcriptomics reveal the evolution and resolution of the immune response in tuberculosis. J Exp Med. 2021;218:e20210915.","journal-title":"J Exp Med"},{"key":"144_CR167","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jinf.2020.03.066","volume":"81","author":"J Ho","year":"2020","unstructured":"Ho J, Bokil NJ, Nguyen PTB, Nguyen TA, Liu MY, Hare N, et al. A transcriptional blood signature distinguishes early tuberculosis disease from latent tuberculosis infection and uninfected individuals in a Vietnamese cohort. J Infect. 2020;81:72\u201380.","journal-title":"J Infect"},{"key":"144_CR168","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3390\/genes13040616","volume":"13","author":"S Natarajan","year":"2022","unstructured":"Natarajan S, Ranganathan M, Hanna LE, Tripathy S. transcriptional profiling and deriving a seven-gene signature that discriminates active and latent tuberculosis: an integrative bioinformatics approach. Genes. 2022;13:616.","journal-title":"Genes"},{"key":"144_CR169","doi-asserted-by":"publisher","first-page":"22072","DOI":"10.1038\/s41598-020-78793-2","volume":"10","author":"JD Petrilli","year":"2020","unstructured":"Petrilli JD, Ara\u00fajo LE, da Silva LS, Laus AC, M\u00fcller I, Reis RM, et al. Whole blood mRNA expression-based targets to discriminate active tuberculosis from latent infection and other pulmonary diseases. Sci Rep. 2020;10:22072.","journal-title":"Sci Rep"},{"key":"144_CR170","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s43856-022-00086-8","volume":"2","author":"SC Mendelsohn","year":"2022","unstructured":"Mendelsohn SC, Mbandi SK, Fiore-Gartland A, Penn-Nicholson A, Musvosvi M, Mulenga H, et al. Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR. Commun Med. 2022;2:1\u201313.","journal-title":"Commun Med"},{"key":"144_CR171","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/s12879-023-08342-5","volume":"23","author":"TR Richardson","year":"2023","unstructured":"Richardson TR, Smith B, Malherbe ST, Shaw JA, Noor F, MacDonald C, et al. Field evaluation of a point-of-care triage test for active tuberculosis (TriageTB). BMC Infect Dis. 2023;23:447.","journal-title":"BMC Infect Dis"},{"key":"144_CR172","doi-asserted-by":"publisher","first-page":"102138","DOI":"10.1016\/j.tube.2021.102138","volume":"131","author":"NP Long","year":"2021","unstructured":"Long NP, Phat NK, Yen NTH, Park S, Park Y, Cho Y-S, et al. A 10-gene biosignature of tuberculosis treatment monitoring and treatment outcome prediction. Tuberculosis. 2021;131:102138.","journal-title":"Tuberculosis"},{"key":"144_CR173","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-020-1087-x","volume":"3","author":"D Sivakumaran","year":"2020","unstructured":"Sivakumaran D, Jenum S, Vaz M, Selvam S, Ottenhoff THM, Haks MC, et al. Combining host-derived biomarkers with patient characteristics improves signature performance in predicting tuberculosis treatment outcomes. Commun Biol. 2020;3:1\u201310.","journal-title":"Commun Biol"},{"key":"144_CR174","doi-asserted-by":"publisher","first-page":"104173","DOI":"10.1016\/j.ebiom.2022.104173","volume":"82","author":"CLR van Doorn","year":"2022","unstructured":"van Doorn CLR, Eckold C, Ronacher K, Ruslami R, van Veen S, Lee J-S, et al. Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment. eBioMedicine. 2022;82:104173.","journal-title":"eBioMedicine."},{"key":"144_CR175","doi-asserted-by":"publisher","first-page":"13646","DOI":"10.1038\/s41598-021-93059-1","volume":"11","author":"R Bayaa","year":"2021","unstructured":"Bayaa R, Ndiaye MDB, Chedid C, Kokhreidze E, Tukvadze N, Banu S, et al. Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoring. Sci Rep. 2021;11:13646.","journal-title":"Sci Rep"},{"key":"144_CR176","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1080\/22221751.2021.1915184","volume":"10","author":"Q Ruan","year":"2021","unstructured":"Ruan Q, Yang Q, Gao Y, Wu J, Lin S, Zhou J-Y, et al. Transcriptional signatures of human peripheral blood mononuclear cells can identify the risk of tuberculosis progression from latent infection among individuals with silicosis. Emerg Microbes Infect. 2021;10:1536\u201344.","journal-title":"Emerg Microbes Infect"},{"key":"144_CR177","doi-asserted-by":"publisher","first-page":"e0274257","DOI":"10.1371\/journal.pone.0274257","volume":"17","author":"M Herrera","year":"2022","unstructured":"Herrera M, Keynan Y, McLaren PJ, Isaza JP, Abrenica B, L\u00f3pez L, et al. Gene expression profiling identifies candidate biomarkers for new latent tuberculosis infections. A cohort study. PLoS ONE. 2022;17:e0274257.","journal-title":"PLoS ONE"},{"key":"144_CR178","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1186\/s12879-020-05116-1","volume":"20","author":"PKW Kwan","year":"2020","unstructured":"Kwan PKW, Periaswamy B, De Sessions PF, Lin W, Molton JS, Naftalin CM, et al. A blood RNA transcript signature for TB exposure in household contacts. BMC Infect Dis. 2020;20:403.","journal-title":"BMC Infect Dis"},{"key":"144_CR179","first-page":"170","volume":"111","author":"JP Zellweger","year":"2020","unstructured":"Zellweger JP, Sotgiu G, Corradi M, Durando P. The diagnosis of latent tuberculosis infection (LTBI): currently available tests, future developments, and perspectives to eliminate tuberculosis (TB): The diagnosis of latent tuberculosis infection (LTBI). Med Lav Work Environ Health. 2020;111:170\u201383.","journal-title":"Med Lav Work Environ Health"},{"key":"144_CR180","doi-asserted-by":"publisher","first-page":"104174","DOI":"10.1016\/j.ebiom.2022.104174","volume":"82","author":"Y Hamada","year":"2022","unstructured":"Hamada Y, Penn-Nicholson A, Krishnan S, Cirillo DM, Matteelli A, Wyss R, et al. Are mRNA based transcriptomic signatures ready for diagnosing tuberculosis in the clinic? - A review of evidence and the technological landscape. eBioMedicine. 2022;82:104174.","journal-title":"eBioMedicine."}],"container-title":["One Health Outlook"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42522-025-00144-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s42522-025-00144-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s42522-025-00144-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T18:03:47Z","timestamp":1744221827000},"score":1,"resource":{"primary":{"URL":"https:\/\/onehealthoutlook.biomedcentral.com\/articles\/10.1186\/s42522-025-00144-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,10]]},"references-count":180,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["144"],"URL":"https:\/\/doi.org\/10.1186\/s42522-025-00144-w","relation":{},"ISSN":["2524-4655"],"issn-type":[{"value":"2524-4655","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,10]]},"assertion":[{"value":"12 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}